Page 102 - JCTR-11-4
P. 102

Journal of Clinical and
            Translational Research                                       NADPH oxidase inhibition in a rodent stroke model



            Appendix



            Table A1. Glossary of antibodies used in immunofluorescence

            Immunohistochemistry  Endogenous block antibody   Primary antibody   Secondary antibody   Fluorescent
            staining combination  (2‑h room temperature   (4°C overnight incubation)  (2‑h room temperature incubation)  probe
                              incubation)
            NeuN and DAPI     -                     Rabbit anti-NeuN (1:500;   Goat anti-rabbit IgG AlexaFluor 546   DAPI 10 mg/mL
                                                    AB177487, Abcam, UK)  (1:500; A1101, Invitrogen, UK)  (1:1000; D3571,
                                                                                                 Invitrogen, UK)
                                                                      1
            NeuN and BrdU     Goat anti-rabbit IgG (heavy and  Rat anti-BrdU (BU1/75 [ICR )  Goat anti-rabbit IgG AlexaFluor 546   -
                              light chains) (1:300; 15450834,   (1:200; AB6326, Abcam, UK);  (1:500; A1101, Invitrogen, UK); Goat
                              Fisher, UK)           Rabbit anti-NeuN (1:500;   anti-rat IgG AlexaFluor 488 (1:400;
                                                    AB177487, Abcam, UK)  AB150157, Abcam, UK)
            CD31              -                     Rabbit anti-CD31 (1:200:   Goat anti-rabbit IgG AlexaFluor 546   DAPI 10 mg/mL
                                                    AB222783; Abcam, UK)  (1:800; A1101, Invitrogen, UK)  (1:1000; D3571,
                                                                                                 Invitrogen, UK)
            Abbreviations: BrdU: 5-bromo-2’-deoxyuridine; DAPI: 4’,6-diamidino-2-phenylindole nuclear DNA stain; IgG: Immunoglobulin G; NeuN: Neuronal
            nuclei; UK: United Kingdom.





















































            Volume 11 Issue 4 (2025)                        96                            doi: 10.36922/jctr.25.00018
   97   98   99   100   101   102   103   104   105   106   107